Andreu-Sanz David, Kobold Sebastian
Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Lindwurmstrasse 2a, 80337 Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, 81675 Munich, Germany.
Cancers (Basel). 2023 Mar 8;15(6):1650. doi: 10.3390/cancers15061650.
Historically, CD8 T cells have been considered the most relevant effector cells involved in the immune response against tumors and have therefore been the focus of most cancer immunotherapy approaches. However, CD4 T cells and their secreted factors also play a crucial role in the tumor microenvironment and can orchestrate both pro- and antitumoral immune responses. Depending on the cytokine milieu to which they are exposed, CD4 T cells can differentiate into several phenotypically different subsets with very divergent effects on tumor progression. In this review, we provide an overview of the current knowledge about the role of the different T helper subsets in the immune system, with special emphasis on their implication in antitumoral immune responses. Furthermore, we also summarize therapeutic applications of each subset and its associated cytokines in the adoptive cell therapy of cancer.
从历史上看,CD8 T细胞一直被认为是参与抗肿瘤免疫反应的最相关效应细胞,因此一直是大多数癌症免疫治疗方法的重点。然而,CD4 T细胞及其分泌的因子在肿瘤微环境中也起着关键作用,并且可以协调促肿瘤和抗肿瘤免疫反应。根据它们所处的细胞因子环境,CD4 T细胞可以分化为几个表型不同的亚群,这些亚群对肿瘤进展具有非常不同的影响。在这篇综述中,我们概述了目前关于不同辅助性T细胞亚群在免疫系统中的作用的知识,特别强调它们在抗肿瘤免疫反应中的意义。此外,我们还总结了每个亚群及其相关细胞因子在癌症过继性细胞治疗中的治疗应用。